Leberle R, Ernstberger A, Loibl M, Merkl J, Bunz M, Creutzenberg M, Trabold B
Department of Anesthesiology, University Medical Center, Germany.
Department of Trauma Surgery, University Medical Center, Germany.
Injury. 2015 Jan;46(1):105-9. doi: 10.1016/j.injury.2014.08.039. Epub 2014 Sep 4.
Initial fluid resuscitation in trauma is still controversial. Hydroxyethyl starch (HES), a commonly used fluid for resuscitation in trauma patients, has potential nephrotoxic effects. Advancing age is a known risk factor for acute kidney injury (AKI) in trauma patients. Therefore, the objective of this study was to evaluate the impact of large volumes of HES 130/0.4 on renal function in trauma patients, with a particular focus on the significance of age.
A retrospective review of all patients admitted to the Trauma Centre of the University Hospital Regensburg from September 1, 2007 to December 31, 2012 was performed. This investigation used data from the TraumaRegister of the German Trauma Society (DGU®), including preclinical data from the prehospital emergency physician's protocol, the patient data management system of the intensive care units and the anaesthesia protocols of the emergency room and the operating room. AKI was evaluated according to the risk, injury, failure, loss, or end-stage kidney disease (RIFLE) criteria. The rate of AKI and the rate of renal replacement therapy (RRT) were compared between patients who received<2000ml HES 130/0.4 during the first 24h (L-HES) after trauma and patients who received≥2000ml HES 130/0.4 during the first 24h (H-HES) after trauma. An additional sub analysis of patients older than 59 years of age was performed.
A total of 260 patients were included. Although patients in the H-HES group showed a higher injury severity score, the incidence of AKI and RRT were comparable. Furthermore, the sub analysis of patients older than 59 years of age also demonstrated similar results regarding incidence of AKI and the rate of RRT.
Fluid resuscitation with more than 2000ml HES (130kD/0.4) during the first twenty four hours after trauma was not associated with an increased incidence of AKI or need for RRT in trauma patients compared to patients who were administered<2000ml HES (130kD/0.4). The analysis of patients older than 59 years of age did not demonstrate any difference in the incidence of AKI or the need for RRT.
创伤后的初始液体复苏仍存在争议。羟乙基淀粉(HES)是创伤患者常用的复苏液体,具有潜在的肾毒性作用。年龄增长是创伤患者急性肾损伤(AKI)的已知危险因素。因此,本研究的目的是评估大量使用130/0.4的HES对创伤患者肾功能的影响,特别关注年龄的意义。
对2007年9月1日至2012年12月31日期间入住雷根斯堡大学医院创伤中心的所有患者进行回顾性研究。本调查使用了德国创伤协会(DGU®)创伤登记处的数据,包括院前急救医生记录中的临床前数据、重症监护病房的患者数据管理系统以及急诊室和手术室的麻醉记录。根据风险、损伤、衰竭、丧失或终末期肾病(RIFLE)标准评估AKI。比较创伤后24小时内接受<2000ml 130/0.4的HES(低剂量HES组)和接受≥2000ml 130/0.4的HES(高剂量HES组)患者的AKI发生率和肾脏替代治疗(RRT)率。对年龄大于59岁的患者进行了额外的亚组分析。
共纳入260例患者。尽管高剂量HES组患者的损伤严重程度评分较高,但AKI和RRT的发生率相当。此外,对年龄大于59岁患者的亚组分析在AKI发生率和RRT率方面也显示了类似结果。
与接受<2000ml 130/0.4的HES的患者相比,创伤后24小时内使用超过2000ml HES(130kD/0.4)进行液体复苏与创伤患者AKI发生率增加或RRT需求无关。对年龄大于59岁患者的分析未显示AKI发生率或RRT需求有任何差异。